-Interview about the last paper nov 2023. Interview in farmaforum. European consortium . FibroHeart experiments at diamond and ALBA synchrotron facilities -predoctoral position offered -OpenLab grant and IFEMA presentation

                                                                   November 2023

News papers publishing our discoveries:

Infosalus: 

https://www.infosalus.com/asistencia/noticia-ibbtec-avanza-sistema-transportar-farmaco-experimental-tratamiento-fibrosis-20231129185028.html 

Cantabria economia:

https://www.cantabriaeconomica.com/empresas/el-ibbtec-disena-un-sistema-para-transportar-un-farmaco-experimental-contra-la-fibrosis/

Interview to Ana V Villar PI of FIBROHEART about the last scientific publication of her group:

                    

                 https://web.unican.es/noticias/Paginas/2023/11/nanofarmaco-experimental-fibrosis.aspx 

                    https://youtu.be/zFnNpQ1DJzI?si=jFEILgXhC4K1oPVD 

Fibroblast-derived extracellular vesicles as trackable efficient transporters of an experimental nanodrug with fibrotic heart and lung targeting. Published in Theranostics 2024, Vol. 14, Issue 1

                                                            December 2022

Interview to Ana V Villar PI of FIBROHEART in farmaforum magazine. Follow this link:

https://www.farmabiotec.com/revistas/numero-4-invierno-2022-2022

Ana V Villar director of a symposium accepted at the 45th SEBBM congress (Zaragoza 5-8 September 2023)

                                                        October 2022    

We are part of a european consortium that start with the partnership of 13 universities.

Fibroheart group was selected to belong to this european consortium

https://twitter.com/Nanomed_CSIC/status/1582318677235765250?t=b21vlnilPJHig_1fHeSQiw&s=19

                                                         September 2022

- Invitation to explain our research at the IFEMA Madrid Congress Health & Research forum  FARMA BIOTECH FARMAFORUM next month 

- Our FIBROHEAT group has been selected as a beneficiary of an OpenLab-CEO 2022 OpenLab-CEO grant. Thanks to this grant one of our projects will be oriented to patent some of our potential anti-fibrotic solutions. Congratulations to the group.

-We start an interesting collaboration with CSIC Madrid on organoids. Wellcome Esther.

-Predoctoral position is available for application from now until the end of September 2022. Write to villarav@unican.es with your CV, motivation letter and degree.

August 2022

 -Look at FibroHeart you tube chanel 

https://www.youtube.com/watch?v=W7d-fUEU22E 

-Predoctoral position available

Predoctoral position is available for application from now until September 2022. Write to villarav@unican.es with your CV, motivation letter and degree.

Look at the hiring section of this blog